Potential Therapeutic Targets for Combination Antibody Therapy Against Staphylococcus aureus Infections
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Despite the significant advances in antibiotic treatments and therapeutics, Staphylococcus aureus (S. aureus) remains a formidable pathogen, primarily due to its rapid acquisition of antibiotic resistance. Known for its array of virulence factors, including surface proteins that promote adhesion to host tissues, enzymes that break down host barriers, and toxins that contribute to immune evasion and tissue destruction, S. aureus poses a serious health threat. Both the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) classify S. aureus as an ESKAPE pathogen, recognizing it as a critical threat to global health. The increasing prevalence of drug-resistant S. aureus underscores the need for new therapeutic strategies. This review discusses a promising approach that combines monoclonal antibodies targeting multiple S. aureus epitopes, offering synergistic efficacy in treating infections. Such strategies aim to reduce the capacity of the pathogen to develop resistance, presenting a potent adjunct or alternative to conventional antibiotic treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, peptide-based inhibitors have proven promising in interrupting the FNBP union with fibronectin, thereby reducing bacterial adhesion and in vitro biofilms [88].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic resistance in Staphylococcus aureus. Current status and future prospects
Foster, T. J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux007 · Cited by 845
Molecular Mechanisms of Drug Resistance in Staphylococcus aureus
Mlynarczyk-Bonikowska, B., Kowalewski, C., Krolak-Ulinska, A., & Marusza, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158088 · Cited by 412
Kuklin, N. A., Clark, D. J., Secore, S., Cook, J., Cope, L. D., McNeely, T., Noble, L., Brown, M. J., Zorman, J. K., Wang, X. M., et al. (2006) · Infection and Immunity · doi:10.1128/iai.74.4.2215-2223.2006 · Cited by 264
Corrigan, R. M., Miajlovic, H., & Foster, T. J. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-22 · Cited by 226
Staphylococcus aureus Redirects Central Metabolism to Increase Iron Availability
Friedman, D. B., Stauff, D. L., Pishchany, G., Whitwell, C. W., Torres, V. J., & Skaar, E. P. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020087 · Cited by 222
Staphylococcus aureus heme and siderophore-iron acquisition pathways
Conroy, B. S., Grigg, J. C., Kolesnikov, M., Morales, L. D., & Murphy, M. E. P. (2019) · BioMetals · doi:10.1007/s10534-019-00188-2 · Cited by 73
Research works printed but not linked: 116
- Lam, 2023, The Golden Grapes of Wrath–Staphylococcus aureus Bacteremia: A Clinical Review, Am. J. Med., 136, 19, 10.1016/j.amjmed.2022.09.017 · DOI
- Lakhundi, 2018, Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology, Clin. Microbiol. Rev., 31, e00020-18, 10.1128/CMR.00020-18 · DOI · Paper page
- Tong, 2015, Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management, Clin. Microbiol. Rev., 28, 603, 10.1128/CMR.00134-14 · DOI · Paper page
- Chand, U., Priyambada, P., and Kushawaha, P.K. (2023). Staphylococcus aureus Vaccine Strategy: Promise and Challenges. Microbiol. Res., 271. · DOI
- Douglas, E.J.A., and Laabei, M. (2023). Staph Wars: The Antibiotic Pipeline Strikes Back. Microbiology, 169. · DOI · Paper page
- Linz, M.S., Mattappallil, A., Finkel, D., and Parker, D. (2023). Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections. Antibiotics, 12. · DOI · Paper page
- Liu, K., Wang, C., Zhou, X., Guo, X., Yang, Y., Liu, W., Zhao, R., and Song, H. (2024). Bacteriophage Therapy for Drug-Resistant Staphylococcus aureus Infections. Front. Cell. Infect. Microbiol., 14. · DOI · Paper page
- Jiang, 2023, Virulence Attributes of Successful Methicillin-Resistant Staphylococcus aureus Lineages, Clin. Microbiol. Rev., 36, e00148-22, 10.1128/cmr.00148-22 · DOI · Paper page
- Turner, 2019, Methicillin-Resistant Staphylococcus aureus: An Overview of Basic and Clinical Research, Nat. Rev. Microbiol., 17, 203, 10.1038/s41579-018-0147-4 · DOI · Paper page
- Thampi, 2015, Multicenter Study of Health Care Cost of Patients Admitted to Hospital with Staphylococcus aureus Bacteremia: Impact of Length of Stay and Intensity of Care, Am. J. Infect. Control, 43, 739, 10.1016/j.ajic.2015.01.031 · DOI
- Miller, 2024, ESKAPE Pathogens: Antimicrobial Resistance, Epidemiology, Clinical Impact and Therapeutics, Nat. Rev. Microbiol., 22, 598, 10.1038/s41579-024-01054-w · DOI · Paper page
- Karauzum, 2017, Adaptive Immunity against Staphylococcus aureus, Curr. Top. Microbiol. Immunol., 409, 419
- Brown, A.F., Murphy, A.G., Lalor, S.J., Leech, J.M., O’Keeffe, K.M., Aogáin, M.M., O’Halloran, D.P., Lacey, K.A., Tavakol, M., and Hearnden, C.H. (2015). Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection. PLOS Pathog., 11. · DOI · Paper page
- Francis, 2021, Identification of CD4+ T Cell Epitopes from Staphylococcus aureus Secretome Using Immunoinformatic Prediction and Molecular Docking, BioTechnologia, 102, 43, 10.5114/bta.2021.103761 · DOI
- Guo, Y., Song, G., Sun, M., Wang, J., and Wang, Y. (2020). Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus. Front. Cell. Infect. Microbiol., 10. · DOI · Paper page
- Shariati, A., Dadashi, M., Moghadam, M.T., van Belkum, A., Yaslianifard, S., and Darban-Sarokhalil, D. (2020). Global Prevalence and Distribution of Vancomycin Resistant, Vancomycin Intermediate and Heterogeneously Vancomycin Intermediate Staphylococcus aureus Clinical Isolates: A Systematic Review and Meta-Analysis. Sci. Rep., 10. · DOI · Paper page
- Cavalcanti, 2010, Teicoplanin versus Vancomycin for Proven or Suspected Infection, Cochrane Database Syst. Rev., 6, CD007022
- Esposito, S., Blasi, F., Curtis, N., Kaplan, S., Lazzarotto, T., Meschiari, M., Mussini, C., Peghin, M., Rodrigo, C., and Vena, A. (2023). New Antibiotics for Staphylococcus aureus Infection: An Update from the World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Italian Society of Anti-Infective Therapy (SITA). Antibiotics, 12. · DOI
- Chan, 2015, Ceftobiprole- and Ceftaroline-Resistant Methicillin-Resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 59, 2960, 10.1128/AAC.05004-14 · doi:10.1128/aac.05004-14
- Minter, 2023, Executive Summary: State-of-The-Art Review: Contemporary Management of Staphylococcus aureus Bacteremia: Controversies in Clinical Practice, Clin. Infect. Dis., 77, 1489, 10.1093/cid/ciad525 · doi:10.1093/cid/ciad525
- Liu, 2011, Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children, Clin. Infect. Dis., 52, e18, 10.1093/cid/ciq146 · DOI · Paper page
- Lambert, 2011, IDSA Guidelines on the Treatment of MRSA Infections in Adults and Children, AFP, 84, 455
- Dinges, M.M., Orwin, P.M., and Schlievert, P.M. (2000). Exotoxins of Staphylococcus aureus. Clin. Microbiol. Rev., 13. · DOI · Paper page
- Proctor, L.L., Ward, W.L., Roggy, C.S., Koontz, A.G., Clark, K.M., Quinn, A.P., Schroeder, M., Brooks, A.E., Small, J.M., and Towne, F.D. (2021). Potential Therapeutic Targets for Combination Antibody Therapy against Pseudomonas aeruginosa Infections. Antibiotics, 10. · DOI
- Otto, 2014, Staphylococcus aureus Toxins, Curr. Opin. Microbiol., 17, 32, 10.1016/j.mib.2013.11.004 · DOI · Paper page
- Howden, 2023, Staphylococcus aureus Host Interactions and Adaptation, Nat. Rev. Microbiol., 21, 380, 10.1038/s41579-023-00852-y · DOI · Paper page
- Plotkin, S.A., Orenstein, W.A., and Offit, P.A. (2018). Plotkin’s Vaccines, Elsevier.
- Krakauer, T. (2019). Staphylococcal Superantigens: Pyrogenic Toxins Induce Toxic Shock. Toxins, 11. · DOI
- Murray, 2005, Recognition and Management of Staphylococcus aureus Toxin-Mediated Disease, Intern. Med. J., 35, S106, 10.1111/j.1444-0903.2005.00984.x · doi:10.1111/j.1444-0903.2005.00984.x
- Brooks, B.D., Brooks, A.E., and Grainger, D.W. (2012). Antimicrobial Medical Devices in Preclinical Development and Clinical Use. Biomaterials Associated Infection, Springer. · DOI
- Joh, 1999, Role of Fibronectin-Binding MSCRAMMs in Bacterial Adherence and Entry into Mammalian Cells, Matrix Biol., 18, 211, 10.1016/S0945-053X(99)00025-6 · DOI · Paper page
- Nilsson, 1998, Vaccination with a Recombinant Fragment of Collagen Adhesin Provides Protection against Staphylococcus aureus-Mediated Septic Death, J. Clin. Investig., 101, 2640, 10.1172/JCI1823 · DOI · Paper page
- Schennings, 1993, Immunization with Fibronectin Binding Protein from Staphylococcus aureus Protects against Experimental Endocarditis in Rats, Microb. Pathog., 15, 227, 10.1006/mpat.1993.1073 · DOI
- Perkins, 1998, Clumping Factor B (ClfB), a New Surface-Located Fibrinogen-Binding Adhesin of Staphylococcus aureus, Mol. Microbiol., 30, 245, 10.1046/j.1365-2958.1998.01050.x · DOI · Paper page
- Nanavaty, 1998, The Fibrinogen-Binding MSCRAMM (Clumping Factor) of Staphylococcus aureus Has a Ca2+-Dependent Inhibitory Site, J. Biol. Chem., 273, 6821, 10.1074/jbc.273.12.6821 · DOI · Paper page
- McDevitt, 1995, Identification of the Ligand-Binding Domain of the Surface-Located Fibrinogen Receptor (Clumping Factor) of Staphylococcus aureus, Mol. Microbiol., 16, 895, 10.1111/j.1365-2958.1995.tb02316.x · DOI · Paper page
- Hartford, 2001, Identification of Residues in the Staphylococcus aureus Fibrinogen-Binding MSCRAMM Clumping Factor A (ClfA) That Are Important for Ligand Binding *, J. Biol. Chem., 276, 2466, 10.1074/jbc.M007979200 · DOI · Paper page
- Deivanayagam, 2002, A Novel Variant of the Immunoglobulin Fold in Surface Adhesins of Staphylococcus aureus: Crystal Structure of the Fibrinogen-Binding MSCRAMM, Clumping Factor A, EMBO J., 21, 6660, 10.1093/emboj/cdf619 · DOI · Paper page
- Vastag, 2001, New Vaccine Decreases Rate of Nosocomial Infections, JAMA, 285, 1565, 10.1001/jama.285.12.1565-JMN0328-3-1 · doi:10.1001/jama.285.12.1565-jmn0328-3-1
- Shkreta, 2006, DNA Immunization of Dairy Cows with the Clumping Factor A of Staphylococcus aureus, Vaccine, 24, 1997, 10.1016/j.vaccine.2005.11.033 · doi:10.1016/j.vaccine.2005.11.033
- Ganesh, 2011, Structural and Biochemical Characterization of Staphylococcus aureus Clumping Factor B/Ligand Interactions, J. Biol. Chem., 286, 25963, 10.1074/jbc.M110.217414 · DOI · Paper page
- Schaffer, 2006, Immunization with Staphylococcus aureus Clumping Factor B, a Major Determinant in Nasal Carriage, Reduces Nasal Colonization in a Murine Model, Infect. Immun., 74, 2145, 10.1128/IAI.74.4.2145-2153.2006 · DOI · Paper page
- Barbu, E.M., Ganesh, V.K., Gurusiddappa, S., Mackenzie, R.C., Foster, T.J., Sudhof, T.C., and Höök, M. (2010). β-Neurexin Is a Ligand for the Staphylococcus aureus MSCRAMM SdrC. PLoS Pathog., 6. · DOI · Paper page
- Kerrigan, 2002, Multiple Mechanisms for the Activation of Human Platelet Aggregation by Staphylococcus aureus: Roles for the Clumping Factors ClfA and ClfB, the Serine–Aspartate Repeat Protein SdrE and Protein A, Mol. Microbiol., 44, 1033, 10.1046/j.1365-2958.2002.02935.x · DOI · Paper page
- Huesca, 2002, Adhesion and Virulence Properties of Epidemic Canadian Methicillin-Resistant Staphylococcus aureus Strain 1: Identification of Novel Adhesion Functions Associated with Plasmin-Sensitive Surface Protein, J. Infect. Dis., 185, 1285, 10.1086/340123 · DOI
- Roche, 2003, The Staphylococcus aureus Surface Protein SasG and Its Homologues Promote Bacterial Adherence to Human Desquamated Nasal Epithelial Cells, Microbiology, 149, 2759, 10.1099/mic.0.26412-0 · DOI · Paper page
- Josefsson, 2005, The Surface Protein Pls of Methicillin-Resistant Staphylococcus aureus Is a Virulence Factor in Septic Arthritis, Infect. Immun., 73, 2812, 10.1128/IAI.73.5.2812-2817.2005 · doi:10.1128/iai.73.5.2812-2817.2005
- Hussain, 2009, Expression of Pls (Plasmin Sensitive) in Staphylococcus aureus Negative for Pls Reduces Adherence and Cellular Invasion and Acts by Steric Hindrance, J. Infect. Dis., 200, 107, 10.1086/599359 · DOI · Paper page
- Tung, 2000, A Bone Sialoprotein-Binding Protein from Staphylococcus aureus: A Member of the Staphylococcal Sdr Family, Biochem. J., 345, 611, 10.1042/bj3450611 · doi:10.1042/bj3450611 · Paper page
- Hynes, 2000, Hyaluronidases of Gram-Positive Bacteria, FEMS Microbiol. Lett., 183, 201, 10.1111/j.1574-6968.2000.tb08958.x · doi:10.1111/j.1574-6968.2000.tb08958.x · Paper page
- Kumar, N.G., Contaifer, D., Wijesinghe, D.S., and Jefferson, K.K. (2021). Staphylococcus aureus Lipase 3 (SAL3) Is a Surface-Associated Lipase That Hydrolyzes Short Chain Fatty Acids. PLoS ONE, 16. · DOI
- Alkuraythi, D. (2024). Virulence Factors and Pathogenicity of Staphylococcus aureus, IntechOpen. · DOI
- Taj, Z., and Chattopadhyay, I. (2024, October 03). Staphylococcus aureus Virulence Factors and Biofilm Components: Synthesis, Structure, Function and Inhibitors. Available online: https://colab.ws/articles/10.1007%2F978-981-99-8799-3_8. · DOI
- Sibbald, 2006, Mapping the Pathways to Staphylococcal Pathogenesis by Comparative Secretomics, Microbiol. Mol. Biol. Rev., 70, 755, 10.1128/MMBR.00008-06 · DOI · Paper page
- Quiblier, C., Seidl, K., Roschitzki, B., Zinkernagel, A.S., Berger-Bächi, B., and Senn, M.M. (2013). Secretome Analysis Defines the Major Role of SecDF in Staphylococcus aureus Virulence. PLoS ONE, 8. · DOI
- Kanonenberg, K., Spitz, O., Erenburg, I.N., Beer, T., and Schmitt, L. (2018). Type I Secretion System—It Takes Three and a Substrate. FEMS Microbiol. Lett., 365. · DOI
- Famelis, 2021, Type VII Secretion Systems: Structure, Functions and Transport Models, Nat. Rev. Microbiol., 19, 567, 10.1038/s41579-021-00560-5 · DOI
- Yamada, 2007, Analysis of Twin-Arginine Translocation Pathway Homologue in Staphylococcus aureus, Curr. Microbiol., 55, 14, 10.1007/s00284-006-0461-3 · doi:10.1007/s00284-006-0461-3
- Tran, 2023, Current Therapies and Challenges for the Treatment of Staphylococcus aureus Biofilm-Related Infections, Pharmacotherapy, 43, 816, 10.1002/phar.2806 · DOI
- Le, K.Y., and Otto, M. (2015). Quorum-Sensing Regulation in Staphylococci—An Overview. Front. Microbiol., 6. · DOI · Paper page
- Aboelnaga, 2024, Deciphering the Dynamics of Methicillin-Resistant Staphylococcus aureus Biofilm Formation: From Molecular Signaling to Nanotherapeutic Advances, Cell Commun. Signal, 22, 188, 10.1186/s12964-024-01511-2 · DOI
- Tuon, F.F., Suss, P.H., Telles, J.P., Dantas, L.R., Borges, N.H., and Ribeiro, V.S.T. (2023). Antimicrobial Treatment of Staphylococcus aureus Biofilms. Antibiotics, 12. · DOI · Paper page
- Otto, 2014, Phenol-Soluble Modulins, Int. J. Med. Microbiol., 304, 164, 10.1016/j.ijmm.2013.11.019 · DOI · Paper page
- Queck, S.Y., Khan, B.A., Wang, R., Bach, T.-H.L., Kretschmer, D., Chen, L., Kreiswirth, B.N., Peschel, A., DeLeo, F.R., and Otto, M. (2009). Mobile Genetic Element-Encoded Cytolysin Connects Virulence to Methicillin Resistance in MRSA. PLOS Pathog., 5. · DOI · Paper page
- Cheung, 2014, Phenol-Soluble Modulins–Critical Determinants of Staphylococcal Virulence, FEMS Microbiol. Rev., 38, 698, 10.1111/1574-6976.12057 · DOI · Paper page
- Romeo, T. (2008). Staphylococcal Biofilms. Bacterial Biofilms, Springer. · doi:10.1007/978-3-540-75418-3
- Zhu, Z., Hu, Z., Li, S., Fang, R., Ono, H.K., and Hu, D.-L. (2023). Molecular Characteristics and Pathogenicity of Staphylococcus aureus Exotoxins. Int. J. Mol. Sci., 25. · DOI
- Hanzelmann, 2016, Toll-like Receptor 2 Activation Depends on Lipopeptide Shedding by Bacterial Surfactants, Nat. Commun., 7, 12304, 10.1038/ncomms12304 · DOI · Paper page
- Ivancic, 2016, Characterization of Structural Elements in Native Autoinducing Peptides and Non-Native Analogues That Permit the Differential Modulation of AgrC-Type Quorum Sensing Receptors in Staphylococcus aureus, Org. Biomol. Chem., 14, 113, 10.1039/C5OB01735A · DOI · Paper page
- Wu, K., Conly, J., McClure, J.-A., Kurwa, H.A., and Zhang, K. (2020). Arginine Catabolic Mobile Element in Evolution and Pathogenicity of the Community-Associated Methicillin-Resistant Staphylococcus aureus Strain USA300. Microorganisms, 8. · DOI · Paper page
- Maddela, N.R., and García, L.C. (2021). Drug Resistance Mechanism in Staphylococcus aureus. Innovations in Biotechnology for a Sustainable Future, Springer International Publishing.
- Kim, C., Mwangi, M., Chung, M., Milheirço, C., Lencastre, H.d., and Tomasz, A. (2013). The Mechanism of Heterogeneous Beta-Lactam Resistance in MRSA: Key Role of the Stringent Stress Response. PLoS ONE, 8. · DOI · Paper page
- Ohwada, 1999, DNA Vaccination by mecA Sequence Evokes an Antibacterial Immune Response against Methicillin-Resistant Staphylococcus aureus, J. Antimicrob. Chemother., 44, 767, 10.1093/jac/44.6.767 · doi:10.1093/jac/44.6.767
- Stephen, J., Salam, F., Lekshmi, M., Kumar, S.H., and Varela, M.F. (2023). The Major Facilitator Superfamily and Antimicrobial Resistance Efflux Pumps of the ESKAPEE Pathogen Staphylococcus aureus. Antibiotics, 12. · DOI
- Pollitt, E.J.G., Crusz, S.A., and Diggle, S.P. (2015). Staphylococcus aureus Forms Spreading Dendrites That Have Characteristics of Active Motility. Sci. Rep., 5. · DOI
- Kizaki, H., Omae, Y., Tabuchi, F., Saito, Y., Sekimizu, K., and Kaito, C. (2016). Cell-Surface Phenol Soluble Modulins Regulate Staphylococcus aureus Colony Spreading. PLoS ONE, 11. · DOI
- Liu, C.-C., and Lin, M.-H. (2020). Involvement of Heme in Colony Spreading of Staphylococcus aureus. Front. Microbiol., 11. · DOI
- Kumari, P., Nath, Y., Murty, U.S., Ravichandiran, V., and Mohan, U. (2020). Sortase A Mediated Bioconjugation of Common Epitopes Decreases Biofilm Formation in Staphylococcus aureus. Front. Microbiol., 11. · DOI
- Speziale, P., Pietrocola, G., Foster, T.J., and Geoghegan, J.A. (2014). Protein-Based Biofilm Matrices in Staphylococci. Front. Cell. Infect. Microbiol., 4. · DOI · Paper page
- Frees, 2004, Clp ATPases Are Required for Stress Tolerance, Intracellular Replication and Biofilm Formation in Staphylococcus aureus, Mol. Microbiol., 54, 1445, 10.1111/j.1365-2958.2004.04368.x · DOI · Paper page
- Sinha, 1999, Fibronectin-Binding Protein Acts as Staphylococcus aureus Invasin via Fibronectin Bridging to Integrin Alpha5beta1, Cell. Microbiol., 1, 101, 10.1046/j.1462-5822.1999.00011.x · DOI · Paper page
- Dziewanowska, 1999, Fibronectin Binding Protein and Host Cell Tyrosine Kinase Are Required for Internalization of Staphylococcus aureus by Epithelial Cells, Infect. Immun., 67, 4673, 10.1128/IAI.67.9.4673-4678.1999 · DOI · Paper page
- Fowler, 2000, Cellular Invasion by Staphylococcus aureus Involves a Fibronectin Bridge between the Bacterial Fibronectin-Binding MSCRAMMs and Host Cell Beta1 Integrins, Eur. J. Cell Biol., 79, 672, 10.1078/0171-9335-00104 · DOI · Paper page
- Dziewanowska, 2000, Staphylococcal Fibronectin Binding Protein Interacts with Heat Shock Protein 60 and Integrins: Role in Internalization by Epithelial Cells, Infect. Immun., 68, 6321, 10.1128/IAI.68.11.6321-6328.2000 · doi:10.1128/iai.68.11.6321-6328.2000 · Paper page
- Tsompanidou, E., Denham, E.L., Sibbald, M.J.J.B., Yang, X., Seinen, J., Friedrich, A.W., Buist, G., and van Dijl, J.M. (2012). The Sortase A Substrates FnbpA, FnbpB, ClfA and ClfB Antagonize Colony Spreading of Staphylococcus aureus. PLoS ONE, 7. · DOI
- Thappeta, K.R.V., Zhao, L.N., Nge, C.E., Crasta, S., Leong, C.Y., Ng, V., Kanagasundaram, Y., Fan, H., and Ng, S.B. (2020). In-Silico Identified New Natural Sortase A Inhibitors Disrupt S. Aureus Biofilm Formation. Int. J. Mol. Sci., 21. · DOI
- Liu, 2009, Molecular Pathogenesis of Staphylococcus aureus Infection, Pediatr. Res., 65, 71R, 10.1203/PDR.0b013e31819dc44d · DOI · Paper page
- Hejazian, 2024, An Update on Glycerophosphodiester Phosphodiesterases; From Bacteria to Human, Protein J., 43, 187, 10.1007/s10930-024-10190-4 · DOI
- Jung, 2008, Necrotizing Pneumonia Caused by Panton-Valentine Leucocidin-Producing Staphylococcus aureus Originating from a Bartholin’s Abscess, Infect. Dis. Obstet. Gynecol., 2008, 491401, 10.1155/2008/491401 · DOI
- Chen, Y., Liu, Z., Lin, Z., Lu, M., Fu, Y., Liu, G., and Yu, B. (2023). The Effect of Staphylococcus aureus on Innate and Adaptive Immunity and Potential Immunotherapy for S. Aureus-Induced Osteomyelitis. Front. Immunol., 14. · DOI
- Goodyear, 2005, B Cell Superantigens: A Microbe’s Answer to Innate-like B Cells and Natural Antibodies, Springer Semin. Immun., 26, 463, 10.1007/s00281-004-0190-2 · DOI
- Kim, 2010, Nontoxigenic Protein A Vaccine for Methicillin-Resistant Staphylococcus aureus Infections in Mice, J. Exp. Med., 207, 1863, 10.1084/jem.20092514 · DOI · Paper page
- Olson, 2013, Staphylococcus aureus Nuclease Is an SaeRS-Dependent Virulence Factor, Infect. Immun., 81, 1316, 10.1128/IAI.01242-12 · DOI · Paper page
- Guerra, F.E., Borgogna, T.R., Patel, D.M., Sward, E.W., and Voyich, J.M. (2017). Epic Immune Battles of History: Neutrophils vs. Staphylococcus aureus. Front. Cell. Infect. Microbiol., 7. · DOI · Paper page
- Gustafsson, E., Haas, P.-J., Walse, B., Hijnen, M., Furebring, C., Ohlin, M., van Strijp, J.A., and van Kessel, K.P. (2009). Identification of Conformational Epitopes for Human IgG on Chemotaxis Inhibitory Protein of Staphylococcus aureus. BMC Immunol., 10. · doi:10.1186/1471-2172-10-13
- Gustafsson, 2010, Directed Evolution of Chemotaxis Inhibitory Protein of Staphylococcus aureus Generates Biologically Functional Variants with Reduced Interaction with Human Antibodies, Protein Eng. Des. Sel., 23, 91, 10.1093/protein/gzp062 · DOI
- Eisenbeis, J., Saffarzadeh, M., Peisker, H., Jung, P., Thewes, N., Preissner, K.T., Herrmann, M., Molle, V., Geisbrecht, B.V., and Jacobs, K. (2018). The Staphylococcus aureus Extracellular Adherence Protein Eap Is a DNA Binding Protein Capable of Blocking Neutrophil Extracellular Trap Formation. Front. Cell. Infect. Microbiol., 8. · DOI
- Chavakis, 2002, Staphylococcus aureus Extracellular Adherence Protein Serves as Anti-Inflammatory Factor by Inhibiting the Recruitment of Host Leukocytes, Nat. Med., 8, 687, 10.1038/nm728 · DOI · Paper page
- Shukla, 2017, Staphylococcus aureus Biofilm Removal by Targeting Biofilm-Associated Extracellular Proteins, Indian J. Med. Res., 146, S1, 10.4103/ijmr.IJMR_410_15 · DOI
- Nemeth, 1995, Antibodies to Capsular Polysaccharides Are Not Protective against Experimental Staphylococcus aureus Endocarditis, Infect. Immun., 63, 375, 10.1128/iai.63.2.375-380.1995 · doi:10.1128/iai.63.2.375-380.1995
- Fattom, 1996, A Staphylococcus aureus Capsular Polysaccharide (CP) Vaccine and CP-Specific Antibodies Protect Mice against Bacterial Challenge, Infect. Immun., 64, 1659, 10.1128/iai.64.5.1659-1665.1996 · DOI · Paper page
- Fattom, 2015, Efficacy Profile of a Bivalent Staphylococcus aureus Glycoconjugated Vaccine in Adults on Hemodialysis: Phase III Randomized Study, Hum. Vaccin. Immunother., 11, 632, 10.4161/hv.34414 · DOI
- Li, 2015, USA300 and USA500 Clonal Lineages of Staphylococcus aureus Do Not Produce a Capsular Polysaccharide Due to Conserved Mutations in the Cap5 Locus, mBio, 6, e02585-14, 10.1128/mBio.02585-14 · DOI · Paper page
- Hassanzadeh, 2023, Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The Staphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial, Clin. Infect. Dis., 77, 312, 10.1093/cid/ciad218 · DOI
- Clegg, J., Soldaini, E., McLoughlin, R.M., Rittenhouse, S., Bagnoli, F., and Phogat, S. (2021). Staphylococcus aureus Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies. Front. Immunol., 12. · DOI · Paper page
- McKenney, 1999, Broadly Protective Vaccine for Staphylococcus aureus Based on an in Vivo-Expressed Antigen, Science, 284, 1523, 10.1126/science.284.5419.1523 · DOI · Paper page
- Cavacini, 2006, Characterization of the Opsonic and Protective Activity against Staphylococcus aureus of Fully Human Monoclonal Antibodies Specific for the Bacterial Surface Polysaccharide Poly-N-Acetylglucosamine, Infect. Immun., 74, 2742, 10.1128/IAI.74.5.2742-2750.2006 · DOI
- Douglas, 2023, Novel Antimicrobial Strategies to Treat Multi-drug Resistant Staphylococcus aureus Infections, Microb. Biotechnol., 16, 1456, 10.1111/1751-7915.14268 · DOI · Paper page
- Weisman, 2009, Phase 1/2 Double-Blind, Placebo-Controlled, Dose Escalation, Safety, and Pharmacokinetic Study of Pagibaximab (BSYX-A110), an Antistaphylococcal Monoclonal Antibody for the Prevention of Staphylococcal Bloodstream Infections, in Very-Low-Birth-Weight Neonates, Antimicrob. Agents Chemother., 53, 2879, 10.1128/AAC.01565-08 · DOI · Paper page
- Suzuki, 2012, Wall Teichoic Acid Protects Staphylococcus aureus from Inhibition by Congo Red and Other Dyes, J. Antimicrob. Chemother., 67, 2143, 10.1093/jac/dks184 · DOI · Paper page
- Kırmusaoğlu, S. (2016). Staphylococcal Biofilms: Pathogenicity, Mechanism and Regulation of Biofilm Formation by Quorum-Sensing System and Antibiotic Resistance Mechanisms of Biofilm-Embedded Microorganisms. Microbial Biofilms—Importance and Applications, IntechOpen. · DOI
- Weidenmaier, 2017, Structure and Function of Surface Polysaccharides of Staphylococcus aureus, Curr. Top. Microbiol. Immunol., 409, 57
- Parthasarathy, A.K., Chougale, R.A., Parthasarathy, A.K., and Chougale, R.A. (2021). Antibiotic Resistant Staphylococcus aureus. Insights into Drug Resistance in Staphylococcus aureus, IntechOpen. · DOI
- Vestergaard, M., Frees, D., and Ingmer, H. (2019). Antibiotic Resistance and the MRSA Problem. Microbiol. Spectr., 7. · DOI · Paper page
- Lu, R.-M., Hwang, Y.-C., Liu, I.-J., Lee, C.-C., Tsai, H.-Z., Li, H.-J., and Wu, H.-C. (2020). Development of Therapeutic Antibodies for the Treatment of Diseases. J. Biomed. Sci., 27. · DOI · Paper page
- Jones, 2016, Targeted Localized Use of Therapeutic Antibodies: A Review of Non-Systemic, Topical and Oral Applications, Crit. Rev. Biotechnol., 36, 506
Cited by
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Metadata
- Authors
- Ke, S., Kil, H., Roggy, C., Shields, T., Quinn, Z., Quinn, A. P., Small, J. M., Towne, F. D., Brooks, A. E., & Brooks, B. D.
- Venue
- Antibiotics
- Publisher
- MDPI AG
- Published
- 2024-11-05
- Volume
- 13
- Issue
- 11
- Pages
- 1046
- ISSN
- 2079-6382
- Cited by
- 17
- References
- 6
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Potential Therapeutic Targets for Combination Antibody Therapy Against Staphylococcus aureus Infections. https://app.cochat.ai/papers/10.3390/antibiotics13111046
- The paper
- Ke, S., Kil, H., Roggy, C., Shields, T., Quinn, Z., Quinn, A. P., Small, J. M., Towne, F. D., Brooks, A. E., & Brooks, B. D. (2024). Potential Therapeutic Targets for Combination Antibody Therapy Against Staphylococcus aureus Infections. Antibiotics. https://doi.org/10.3390/antibiotics13111046
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.